KOP Posted November 6, 2021 Share Posted November 6, 2021 My wife is stage IV NS NSCLC with no drivers and no response to Keytruda. On 2nd line Docetaxel and Ramuceramab. Looking for small group to connect with to discuss and review related trials and research. Link to comment Share on other sites More sharing options...
LexieCat Posted November 6, 2021 Share Posted November 6, 2021 Hi there, and welcome. I'm in pretty much the same situation--Stage IV, no targetable mutations. I had progression on maintenance therapy (Keytruda and Alimta), after which I enrolled in a clinical trial of TIL (tumor-infiltrating lymphocytes) therapy. After a terrific initial response, I again had progression and pericardial effusion, which proved to have cancer cells. So I'm figuring out my own next move--most likely either a clinical trial of a new monoclonal antibody combined with Keytruda, or a new radiation therapy technique. Link to comment Share on other sites More sharing options...
KOP Posted November 6, 2021 Author Share Posted November 6, 2021 Is there a way we can connect off line? Email or phone? Link to comment Share on other sites More sharing options...
KOP Posted November 6, 2021 Author Share Posted November 6, 2021 That was to Lexiecat. Cab we connect off line somehow. Link to comment Share on other sites More sharing options...
Babs Posted November 6, 2021 Share Posted November 6, 2021 Hi there, You are on the duo that I will go on if the trial I am on doesn’t work. How are you dealing with it? I have Enfortumab infusions which is a clinical trial I am in. I am NSCLC stage IIIB. I wish you all the luck! Link to comment Share on other sites More sharing options...
LexieCat Posted November 6, 2021 Share Posted November 6, 2021 10 hours ago, KOP said: That was to Lexiecat. Cab we connect off line somehow. You can send me a private message, using the envelope icon at the upper right of the page. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.